EUVIMEDEUVIMED entdecken
Crossref

N6-methyladenosine reader YTHDF2 facilitates malignant progression of gallbladder cancer by suppressing NME1 expression

En-Liang Zhu, Ming-Jian Ma, Xin-Gui Wu, Ze-Chuan Chen, Xiang Xu, You Wu, Zhi-De Liu, Yang-Yin-Hui Yu, Zi-Yi Zhao, Qiong-Cong Xu, Xiao-Yu Yin

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von En-Liang Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China; Department of Anesthesiol…. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, RNA-Binding Proteins, Adenosine, NM23 Nucleoside Diphosphate Kinases. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gallbladder carcinoma (GBC) is a highly aggressive malignancy characterized by an extremely poor prognosis and limited therapeutic options. N6-methyladenosine (m6A), the most prevalent post-transcriptional modification in eukaryotic mRNA, plays a pivotal role in regulating tumor progression. Screening of an siRNA library targeting YTH-domain family reader proteins identified YTH domain-containing family protein 2 (YTHDF2) as essential for the malignant phenotype of GBC cells. YTHDF2 was aberrantly upregulated in GBC tissues and served as an independent predictor of poor prognosis. Genetic silencing of YTHDF2 markedly suppressed both proliferation and metastatic potential of GBC cells in vitro and in vivo. Mechanistically, YTHDF2 transcription is upregulated through P300 histone acetyltransferase-mediated H3K27ac modification. YTHDF2 promotes mRNA degradation by binding to m6A-modified sites within the transcript encoding the metastasis suppressor non-metastatic protein 1 (NME1), thereby repressing NME1 expression and accelerating GBC malignancy. Co-treatment with the P300 inhibitor C646 and the m6A modification inhibitor STM2457 synergistically inhibited YTHDF2-mediated GBC malignancy. Collectively, these findings establish the P300-YTHDF2-m6A-NME1 axis as a critical driver of GBC progression and indicate that combined C646 and STM2457 treatment represents a novel and promising therapeutic strategy for GBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsRNA-Binding ProteinsAdenosineNM23 Nucleoside Diphosphate KinasesHumansAnimalsCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationDisease ProgressionMiceMice, NudeRNA MethylationFemaleMale

Stichwörter der Autor:innen

Gallbladder cancerMalignant behaviorN6-methyladenosineNME1YTHDF2

Substanzen

RNA-Binding ProteinsYTHDF2 protein, humanAdenosineN-methyladenosineNM23 Nucleoside Diphosphate KinasesNME1 protein, human

Autor:innen und Institutionen

  • Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China; Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou,…
  • Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
  • Provincial Key Laboratory of Research in Structure Birth Defect Disease and Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510623, Chi…
  • Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: xuqc5@mail.sysu.edu.cn.
  • Department of Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: yinxy@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhu, E. L., Ma, M. J., Wu, X. G., Chen, Z. C., Xu, X., Wu, Y., Liu, Z. D., Yu, Y. Y., Zhao, Z. Y., Xu, Q. C., & Yin, X. Y. (2026). N6-methyladenosine reader YTHDF2 facilitates malignant progression of gallbladder cancer by suppressing NME1 expression. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218754

Vancouver

Zhu EL, Ma MJ, Wu XG, Chen ZC, Xu X, Wu Y, et al. N6-methyladenosine reader YTHDF2 facilitates malignant progression of gallbladder cancer by suppressing NME1 expression. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218754

BibTeX
@article{Zhu2026,
  author = {Zhu, En-Liang and Ma, Ming-Jian and Wu, Xin-Gui and Chen, Ze-Chuan and Xu, Xiang and Wu, You and Liu, Zhi-De and Yu, Yang-Yin-Hui and Zhao, Zi-Yi and Xu, Qiong-Cong and Yin, Xiao-Yu},
  title = {N6-methyladenosine reader YTHDF2 facilitates malignant progression of gallbladder cancer by suppressing NME1 expression},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218754}
}
Kostenlos starten →